Elena Rivolti

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Francesca Palandri, Elena Rossi, Daniela Bartoletti et al. · Blood · 2021 · 55 citations · Full text

Medicine, Hematology, Pharmacology +10

Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients

Fabio Forghieri, Mario Luppi, Monica Morselli et al. · Haematologica · 2007 · 35 citations · Full text

Medicine, Hematology, Oncology +17

Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia

Irene Motta, Dario Consonni, Marina Stroppiano et al. · Scientific Reports · 2021 · 26 citations · Full text

Medicine, Endocrinology, Hematology +17

Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The <scp>DARE</scp> study

Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis et al. · American Journal of Hematology · 2023 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Samantha Pozzi, Massimo Gentile, Stefano Sacchi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16